Security key
H17182108
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 59,826,628
- Total 13F value
- $2,811,325,020
- Share change
- +386,824
- Put/Call ratio
- 179%
- SEC-reported price per share
- $46.98
- Number of holders
- 407
- Value change
- +$6,501,203
- Number of buys
- 167
- Number of sells
- 196
- Shares outstanding
- 96,232,072
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
407
Top holders
10
CRSP full security history
Ownership snapshot
Full 13F holder table
CRISPR Therapeutics AG SEC filings
CRISPR Therapeutics AG company facts
Broader feeds
Ownership snapshot
Top reported holders of CRSP - CRISPR Therapeutics AG - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Capital International Inv...
Disclosed value leader
Capital International Inv...
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 8.2%
Showing 1-6 of 15 holder rows.
Quick read
Capital International Investors leads the comparable SEC ownership view at 8.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Capital International Investors's linked filing trail.
Comparable ownership
Top 5
Capital International Investors
8.2%
ARK Investment Management LLC
8.1%
Sumitomo Mitsui Trust Group, Inc.
3.3%
Amova Asset Management Americas, ...
3.3%
BlackRock Finance, Inc.
2.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Capital International Investors |
13F
Company
|
8.2%
|
$424,802,315
7,865,253 shares
|
— | 30 Jun 2024 |
| ARK Investment Management LLC |
13F
Company
|
8.1%
|
$420,118,712
7,778,536 shares
|
— | 30 Jun 2024 |
| Sumitomo Mitsui Trust Group, Inc. |
13F
Company
|
3.3%
|
$170,213,271
3,151,514 shares
|
— | 30 Jun 2024 |
| Amova Asset Management Americas, Inc. |
13F
Company
|
3.3%
|
$169,992,665
3,151,514 shares
|
— | 30 Jun 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
2.9%
|
$150,028,114
2,777,784 shares
|
— | 30 Jun 2024 |
| T. Rowe Price Investment Management, Inc. |
13F
Company
|
2.8%
|
$147,483,000
2,730,652 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
407
Shares
59,826,628
Rows available
407
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
439
Q3 2024 holders
407
Holder diff
-32
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|